IL18 and neoplasm: An anti-tumor role for IL-18 (formerly called IFNγ-inducing factor) was also proposed, based on its capacity to stimulate the production of IFN-γ by activated lymphocytes, subsequently enhancing apoptosis of tumor cells [24].